Case series: Clinico-pathological studies of gastrointestinal neuroendocrine tumors (GI-NETs)

Abstract

Gastrointestinal neuroendocrine tumors (GI-NET) are one of the rarest cancers that occur with an annual global incidence of 2.5-5/100000 patients. Gastrointestinal NET is the second cancer that affects any individuals, after cancer of the colorectal region. Early identification and early intervention will prevent the mortality of individuals dying due to gastrointestinal neuroendocrine tumors. The main element of prevention is early identification; hence clinicians can identify the rarest cases and can receive enlighten insights to reduce the mortality due to the rarest diseases.

Keywords

• gastrointestinal
• gastrointestinal neuroendocrine tumors (gi-net)
• chromogranin a protein
• neoplasia
• neurofibromatosis
• intra-arterial therapies
• polypoid